An official website of the United States government

Skip to Content

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Biometric Research Program

 

Last Updated:

Predictive Biomarkers in Phase II/III Clinical Trials

Biomarker Targeted Randomized Design

Targeted design randomizes only marker positive patients to treatment or control arm. Untargeted design does not measure marker and randomizes all who otherwise are eligible.

Specify endpoint:
Binary Endpoint
Time to Event (Survival) Endpoint

specify treatment effects:
Specify treatment effects for assay negative and assay positive patients
Specify treatment effects for target negative and target positive patients and specify assays sensitivity and specificity